Search

everythinglearnresearchcommunity

for

Search:↓

HSA nanoparticles can improve tamoxifen delivery for breast cancer treatment, reducing side effects.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Adipose-derived stem cells and platelet-rich plasma together can protect skin and hair from radiotherapy damage.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Erlotinib can cause hair loss and texture changes.

Using dutasteride during hair transplants improves results and reduces hair loss.

Doxorubicin causes heart damage, so early detection and monitoring are important during chemotherapy.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.